Annals of Clinical and Translational Neurology

Top Research Topics at Annals of clinical and translational neurology?

The topics of Internal medicine, Pathology, Disease, Multiple sclerosis and Immunology are the focal point of discussions in the journal. The journal addresses concerns in Internal medicine which are intertwined with other disciplines, such as Gastroenterology, Endocrinology, Oncology and Cardiology. The journal connects research in Pathology with the related topic of White matter.

Topics in Disease were tackled in line with various other fields like Cognition and Bioinformatics. Antibody and Immune system studies are all carried out as a component of the study in Immunology presented. The journal investigates Cerebrospinal fluid research which frequently intersects with Biomarker (medicine).

• Internal medicine (28.25%)
• Pathology (16.16%)
• Disease (14.65%)

What are the most cited papers published in the journal?

• CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease (210 citations)
• Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies (209 citations)
• GRIN2A mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine (188 citations)

Research areas of the most cited articles at Annals of clinical and translational neurology:

The most cited papers investigate areas of study like Internal medicine, Pathology, Disease, Immunology and Multiple sclerosis. The most cited papers address concerns in Internal medicine which are intertwined with other disciplines, such as Gastroenterology, Endocrinology and Oncology. While the journal publications focused on Disease, they were also able to explore topics like Genetics, Cohort and Bioinformatics.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Disease

The previous edition focused in particular on these issues:

The journal primarily tackles Internal medicine, Disease, Gastroenterology, Multiple sclerosis and Epilepsy. Annals of clinical and translational neurology holds forums on Internal medicine that merges themes from other disciplines such as Endocrinology, Oncology and Cardiology. It facilitates discussions on Disease that incorporate concepts from other fields like Genetics and Gene.

The journal tackles studies in Placebo and the interrelated subject of Clinical trial to gain insights into Gastroenterology. While Multiple sclerosis is the key highlight in Annals of clinical and translational neurology, it also covered some subjects on White matter and Hyperintensity. Biomarker (medicine) and Pediatrics are some topics wherein Cohort research discussed in Annals of clinical and translational neurology have an impact.

The most cited articles from the last journal are:

• Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". (42 citations)
• 230 days of ultra long-term subcutaneous EEG: seizure cycle analysis and comparison to patient diary. (12 citations)
• Experiences of telemedicine in neurological out-patient clinics during the COVID-19 pandemic. (11 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Annals of clinical and translational neurology (based on the number of publications) are:

• David A. Lynch (16 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Henrik Zetterberg (13 papers) published 4 papers at the last edition, 3 more than at the previous edition,
• Kaj Blennow (13 papers) published 3 papers at the last edition, 2 more than at the previous edition,
• Bruce L. Miller (13 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Emmanuelle Waubant (12 papers) published 4 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Annals of clinical and translational neurology (based on the number of publications) are:

• Boston Children's Hospital (76 papers) published 15 papers at the last edition, 4 less than at the previous edition,
• Harvard University (72 papers) published 16 papers at the last edition, 5 more than at the previous edition,
• University of California, San Francisco (59 papers) published 9 papers at the last edition, 1 more than at the previous edition,
• National Institutes of Health (51 papers) published 5 papers at the last edition, 3 less than at the previous edition,
• University of Pennsylvania (47 papers) published 7 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.30% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 31.60% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.85% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.51% of all publications and 41.04% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in the Field of Clinical and Translational Neurology

An area which the article could provide additional valuable information is career opportunities for aspiring researchers in the field of clinical and translational neurology. This would prove informative for readers who wish to pursue a career in this area of research.

Budding scientists and medical professionals interested in Internal Medicine, Pathology, Disease, Multiple Sclerosis, and Immunology have a plethora of career opportunities in the niche of clinical and translational neurology. There is a continuous demand for researchers, scientists, lab technicians, and medical writers in this field. As a clinician, a neurologist who applies translational research can contribute significantly to advancements in treatments for neurological diseases.

If studying and working on groundbreaking research fascinates you, this domain offers a vast expanse of opportunities to explore. Alongside the aforementioned roles, you could also work as a faculty member teaching and mentoring students and junior researchers about clinical and translational neurology.

For those looking to embark on this career path with a specific focus on nursing, you could seek guidance from the article on how to become a registered nurse in New Hampshire online. This resource could be particularly helpful if becoming a registered nurse is part of your career plan in neurology.

Overall, a career in clinical and translational neurology could be extremely rewarding with numerous avenues to explore, learn, and contribute to the betterment of healthcare.